Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 14,157,000 | 11,380,000 | 11,118,000 | 12,201,000 | 12,698,000 |
| Cost of Goods | 4,085,000 | 3,410,000 | 3,439,000 | 4,048,000 | 3,841,000 |
| Gross Profit | 10,072,000 | 7,970,000 | 7,679,000 | 8,153,000 | 8,857,000 |
| Operating Expenses | 5,983,000 | 5,689,000 | 5,448,000 | 6,199,000 | 5,402,000 |
| Operating Income | 4,089,000 | 2,281,000 | 2,231,000 | 1,954,000 | 3,455,000 |
| Interest Expense | 265,000 | 135,000 | 253,000 | -29,000 | 318,000 |
| Other Income | -321,000 | -754,000 | -631,000 | -2,104,000 | -101,000 |
| Pre-tax Income | 3,503,000 | 1,392,000 | 1,347,000 | -121,000 | 3,036,000 |
| Income Tax | 737,000 | 299,000 | 164,000 | 309,000 | 563,000 |
| Net Income Continuous | 2,844,000 | 1,117,000 | 1,146,000 | -558,000 | 2,538,000 |
| Minority Interests | -29,000 | -4,000 | -13,000 | 3,000 | -13,000 |
| Net Income | $2,815,000 | $1,113,000 | $1,133,000 | $-555,000 | $2,525,000 |
| EPS Basic Total Ops | 2.25 | 0.89 | 0.91 | -0.44 | 2.01 |
| EPS Basic Continuous Ops | 2.25 | 0.89 | 0.91 | -0.44 | 2.01 |
| EPS Diluted Total Ops | 2.25 | 0.89 | 0.91 | -0.44 | 2.01 |
| EPS Diluted Continuous Ops | 2.25 | 0.89 | 0.91 | -0.44 | 2.01 |
| EBITDA(a) | $4,247,000 | $2,026,000 | $2,162,000 | $425,000 | $3,916,000 |